Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma

The only currently validated treatment for advanced hepatocellular carcinoma (HCC) is sorafenib. However, sorafenib has been mainly studied in patients with HCC developed in cirrhotic liver. Chemotherapy might be more suitable for patients with HCC in non-cirrhotic liver. We report the case of a you...

Descripción completa

Detalles Bibliográficos
Autores principales: Gras, Pauline, Truant, Stéphanie, Boige, Valérie, Ladrat, Laure, Rougier, Philippe, Pruvot, François-René, Hebbar, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: April, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364045/
https://www.ncbi.nlm.nih.gov/pubmed/22666208
http://dx.doi.org/10.1159/000338242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364045/
https://www.ncbi.nlm.nih.gov/pubmed/22666208
http://dx.doi.org/10.1159/000338242

Ejemplares similares